Debt (Details) shares in Thousands			1 Months Ended			3 Months Ended
	Oct. 11, 2024 USD ($)	Jul. 19, 2024 USD ($)	Jul. 19, 2024 USD ($)	Oct. 31, 2023	Apr. 30, 2020 USD ($) $ / shares	Mar. 31, 2025 USD ($) $ / shares shares	Mar. 31, 2024 USD ($)	Dec. 31, 2024 USD ($) $ / shares shares	Jun. 30, 2023 USD ($)	Dec. 31, 2020 USD ($)	Sep. 30, 2015 USD ($)
Debt Instrument [Line Items]
Remaining borrowing capacity						$ 20,000,000.0
Collateral amount						$ 150,000,000.0
Common Stock, Par or Stated Value Per Share | $ / shares						$ 0.0001		$ 0.0001
Common stock, shares issued | shares						135,932		132,646
Conversion rate increase			0.4284
Amortization of debt discount and issuance cost							$ 328,000
Interest expense						$ 1,005,000	3,124,000
Convertible Notes
Debt Instrument [Line Items]
Principal amount		$ 287,500,000	$ 287,500,000		$ 287,500,000
Per annum interest rate (as a percent)		2.25%	2.25%		2.25%
Interest expense							1,945,000
Common Stock, Par or Stated Value Per Share | $ / shares					$ 0.0001
Principal amount per convertible note					$ 1,000
Conversion price (in dollars per share) | $ / shares					$ 38.79
Initial conversion rate					25.7785
Convertible to shares of common stock	7,500,000				7,411,704
Percentage of principal amount converted	100.00%		100.00%
Line Of Credit-UBS
Debt Instrument [Line Items]
Maximum borrowing capacity									$ 100,000,000.0	$ 150,000,000.0	$ 50,000,000.0
Outstanding balance						80,300,000		$ 80,400,000
Credit facility drawn down						(80,000,000.0)
Remaining borrowing capacity						20,000,000.0
Collateral amount						$ 150,000,000.0
Effective interest rate (as a percent)						4.83%
Interest expense						$ 1,000,000.0	$ 1,200,000
Line Of Credit-UBS | SOFR
Debt Instrument [Line Items]
Spread on interest rate (as a percent)				0.50%		0.50%